Literature DB >> 15685176

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

Hans Christian Probst1, Kathy McCoy, Taku Okazaki, Tasuku Honjo, Maries van den Broek.   

Abstract

T cells recognizing self proteins exist without causing autoimmunity in healthy individuals. These autoreactive T cells are kept in check by peripheral tolerance. Using a model for peripheral CD8(+) T cell tolerance resulting from antigen presentation by resting dendritic cells in vivo, we show here that CD8(+) T cell tolerance operates through T cell-intrinsic mechanisms such as deletion or functional inactivation. Peripheral CD8(+) T cell tolerance depended on signaling via the costimulatory molecule PD-1, as an absence of PD-1 converted tolerance induction into priming. Blocking of the costimulatory molecule CTLA-4 resulted in impaired tolerance and enhanced the effect of the absence of PD-1, suggesting that PD-1 and CTLA-4 act synergistically. Thus PD-1 and CTLA-4 are crucial molecules for peripheral CD8(+) T cell tolerance induced by resting dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685176     DOI: 10.1038/ni1165

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  196 in total

1.  T-cell tolerance: central and peripheral.

Authors:  Yan Xing; Kristin A Hogquist
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

2.  Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men.

Authors:  Mohammad Reza Zamani; Firouzeh Akbari Asbagh; Amir Hossein Massoud; Arash Salmaninejad; Ahmad Massoud; Nima Rezaei
Journal:  J Assist Reprod Genet       Date:  2014-11-16       Impact factor: 3.412

Review 3.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

4.  B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.

Authors:  Jang-June Park; Ryusuke Omiya; Yumiko Matsumura; Yukimi Sakoda; Atsuo Kuramasu; Mathew M Augustine; Sheng Yao; Fumihiko Tsushima; Hidehiko Narazaki; Sudarshan Anand; Yingjia Liu; Scott E Strome; Lieping Chen; Koji Tamada
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

5.  PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.

Authors:  Joanne E Konkel; Friederike Frommer; Melanie D Leech; Hideo Yagita; Ari Waisman; Stephen M Anderton
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

Review 6.  Dynamics of dendritic cell-T cell interactions: a role in T cell outcome.

Authors:  Stéphanie Hugues
Journal:  Semin Immunopathol       Date:  2010-07-06       Impact factor: 9.623

7.  Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.

Authors:  Guoping Peng; Shuping Li; Wei Wu; Zhen Sun; Yiqiong Chen; Zhi Chen
Journal:  Immunology       Date:  2007-08-31       Impact factor: 7.397

8.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

9.  Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.

Authors:  Kenneth D Bishop; John E Harris; John P Mordes; Dale L Greiner; Aldo A Rossini; Michael P Czech; Nancy E Phillips
Journal:  Cell Immunol       Date:  2009-02-23       Impact factor: 4.868

10.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Authors:  Madhav D Sharma; Babak Baban; Phillip Chandler; De-Yan Hou; Nagendra Singh; Hideo Yagita; Miyuki Azuma; Bruce R Blazar; Andrew L Mellor; David H Munn
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.